Skip to main content
Text size
A
A
A
Home
About us
At a glance
Board
Executive team
Heritage
Collaborations
Locations
Media room
Press releases
Media contacts
Products
Combivir
Epivir/3TC
Epzicom/Kivexa
Lexiva/Telzir
Rescriptor
Retrovir/AZT
Selzentry/Celsentri
Trizivir
Viracept
Ziagen
R&D
Our commitment to new medicines
Our pipeline
About HIV/AIDS
Key facts
Overview of HIV/AIDS
HIV/AIDS and children
HIV/AIDS and ViiV Healthcare: a timeline
Access
Not-for-profit pricing
Voluntary licensing
Community
Positive Action
Where we operate
Postive Action Program
What we do
Our programmes
Our partners
Publications and multimedia
Contact
Positive Action for Children Fund
What we do
Grant criteria and application
FAQs
Our 2010 grantees
Positive Action Community Grants
Positive Action at work
Workplace materials
News and information
Careers
Careers
UK and European vacancies
US and rest of the world vacancies
How to apply
FAQs
UK privacy statement
US privacy statement
About us
At a glance
Board
Executive team
Heritage
Collaborations
Locations
Print page
Email page
Home
/
About us
/
At a glance
At a glance
ViiV Healthcare is a focused HIV business that brings together the strengths of two world leaders in HIV: GlaxoSmithKline (GSK) and Pfizer
We are a specialised HIV company that is able to draw on the strong heritage of GSK and Pfizer in this therapy area
We have a 19% share of the worldwide HIV market
Our portfolio is built on 10 available medicines
We have an industry-leading pipeline of seven innovative and targeted compounds in development
We are committed to improving access to HIV treatments
© 2009 ViiV Healthcare group of companies. All rights reserved